Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasis
- DOI
- 10.1080/09546634.2016.1255306
- Published
- 2016-11-21
- Container
- Journal of Dermatological Treatment
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/09546634.2016.1255306,
title = {Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasis},
author = {Neil J. Korman and Howard Sofen and Scott Fretzin and Phoebe Rich and Yang Zhao and Vivian Herrera and Judit Nyirady and Nicole Williams and Margaret Mordin and Stephen Tyring},
year = {2016},
journal = {Journal of Dermatological Treatment},
doi = {10.1080/09546634.2016.1255306},
url = {https://doi.org/10.1080/09546634.2016.1255306}
}RIS
TY - JOUR TI - Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasis AU - Neil J. Korman AU - Howard Sofen AU - Scott Fretzin AU - Phoebe Rich AU - Yang Zhao AU - Vivian Herrera AU - Judit Nyirady AU - Nicole Williams AU - Margaret Mordin AU - Stephen Tyring PY - 2016 JO - Journal of Dermatological Treatment DO - 10.1080/09546634.2016.1255306 UR - https://doi.org/10.1080/09546634.2016.1255306 ER -
APA
Korman, N. J., Sofen, H., Fretzin, S., Rich, P., Zhao, Y., Herrera, V., Nyirady, J., Williams, N., Mordin, M., & Tyring, S. (2016). Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasis. Journal of Dermatological Treatment. https://doi.org/10.1080/09546634.2016.1255306
Source records
- crossref · retrieved 2026-09-26T19:47:20.963Z